Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Regulatory News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

Share Price is delayed by 15 minutes
Get Live Data
12.00    0.00 (0.00%)
Bid:
11.50
Ask:
12.50
Spread: 1.00 (8.696%)
Market Cap: £30.13m
ABDX Live PriceLast checked at - London Stock Exchange

Intraday Abingdon Healt. Share Chart

TR-1

19 Aug 2024 13:45

RNS Number : 9686A
Abingdon Health PLC
19 August 2024
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ABINGDON HEALTH PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

14 AUGUST 2024

6. Date on which issuer notified (DD/MM/YYYY):

16 AUGUST 2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

9.8679

9.8679

18,702,013

Position of previous notification (if

applicable)

N/A

N/A

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BLF79J41

18,702,013

9.8679

SUBTOTAL 8. A

18,702,013

9.8679

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Canaccord Genuity Group Inc.

9.8679

9.8679

 

Canaccord Genuity Wealth Group Holdings Limited

9.8679

9.8679

 

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

9.8679

9.8679

 

Canaccord Genuity Wealth Group Limited

9.8679

9.8679

 

Canaccord Genuity Asset Management Limited

9.8679

9.8679

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

 

The change in the percentage of shares held is due entirely to participation in the placing by Abingdon Health plc, the shares from which were admitted to trading on AIM on 14/08/2024.

 

 

Place of completion

BLACKPOOL, ENGLAND

Date of completion

19 AUGUST 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFSFTSIALIS
Date   Source Headline
24th Aug 20214:35 pmRNSPrice Monitoring Extension
24th Aug 202111:05 amRNSSecond Price Monitoring Extn
24th Aug 202111:00 amRNSPrice Monitoring Extension
23rd Aug 20214:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20212:05 pmRNSSecond Price Monitoring Extn
23rd Aug 20212:00 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSLaunch of BioSURE COVID-19 IgG Antibody Self Test
12th Aug 20212:00 pmRNSPrice Monitoring Extension
12th Aug 20217:00 amRNSTrading update
9th Aug 202111:15 amRNSDisclosure of Detailed Grounds for Resistance
27th Jul 20217:00 amRNSPublication of an article regarding AbC-19
23rd Jul 20217:00 amRNSExclusive Manufacturing Agreement with BioSure
9th Jul 20217:00 amRNSPeer reviewed study involving AbC 19
5th Jul 20217:00 amRNSManufacturing Agreement with Bioporto A/S
11th Jun 20214:40 pmRNSSecond Price Monitoring Extn
11th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20214:41 pmRNSSecond Price Monitoring Extn
7th Jun 20214:36 pmRNSPrice Monitoring Extension
27th Apr 20219:05 amRNSSecond Price Monitoring Extn
27th Apr 20219:00 amRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSTrading Update
23rd Apr 20213:02 pmRNSGrant of Options under SAYE Scheme
6th Apr 20211:34 pmRNSDirector Dealing
10th Mar 20214:41 pmRNSSecond Price Monitoring Extn
10th Mar 20214:35 pmRNSPrice Monitoring Extension
10th Mar 20212:06 pmRNSSecond Price Monitoring Extn
10th Mar 20212:00 pmRNSPrice Monitoring Extension
10th Mar 202111:06 amRNSSecond Price Monitoring Extn
10th Mar 202111:00 amRNSPrice Monitoring Extension
9th Mar 20217:00 amRNSInterim Results
24th Feb 20217:00 amRNSData on AbC-19 as CDx for Pfizer-BioNTech Vaccine
23rd Feb 20217:00 amRNSNotice of Interim Results
16th Feb 20217:00 amRNSAbingdon Health Notes Announcement by UK-RTC
9th Feb 20217:00 amRNSCollaboration with Abcam
8th Feb 20217:00 amRNSStatement re Media Article
27th Jan 20216:13 pmRNSMedia Clarification
26th Jan 20217:01 amRNSTrading Update
26th Jan 20217:00 amRNSAppointment of Chief Financial Officer
29th Dec 20207:00 amRNSAbC-19TM Rapid Test Update
15th Dec 20207:00 amRNSADMISSION TO TRADING ON AIM & FIRST DAY DEALINGS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.